duchenne muscular dystrophy and glutathione NCATS Enables a Drug's Path
NCATS Enables a Drug's Path to FDA Approval for Duchenne Muscular Dystrophy National Center for Advancing Translational Sciences Mitochondrial stress responses in Duchenne muscular dystrophy: metabolic dysfunction or adaptive reprogramming? American Journal of Physiology Cell Physiology American Physiological Society Full article: A Hypothesized Therapeutic Role of (Z) Endoxifen in Duchenne Muscular Dystrophy (DMD) Mitochondrial creatine sensitivity is lost in the D2.mdx model of Duchenne muscular dystrophy and rescued by the mitochondrial enhancing compound Olesoxime American Journal of Physiology Cell Physiology American Physiological Society
Pay in 4 interest-free payments of $5.63 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



